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Copyright © 2007 AHC It has been suggested that the degradation of the articular cartilage and osteoarthritis (OA)
are associated with gender and the estrogen hormone. Although many investigators have
reported the presence of the estrogen receptors (ERs) α and β in the articular cartilage, the
localization of these receptors and the difference in their in vivo expression have not yet
been clearly demonstrated. We performed immunofluorescence staining of ERα and ERβ to
elucidate the localization of the ERs and to note the effects of gender and the aging process
on these receptors. The results revealed that ERα and ERβ were expressed in the articular
cartilage and subchondral bone layers of adult rats of both sexes. We also observed the high
expression of these receptors in immature rats. In contrast, their expression levels de-
creased in an ovariectomised model, as a simulation of postmenopause, and in aged female
rats. Therefore, this study suggests the direct effects of estrogen and ER expression on ar-
ticular surface metabolism.
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I. Introduction
Primary osteoarthritis (OA) is a disease caused by the
degradation of the articular cartilage. It occurs in a larger
number of females than males, and the rates of both preva-
lence and incidence increase in postmenopausal women.
Usually, the symptoms of OA are more severe in women
than in men. Therefore, it has been suggested that both
gender and the hormone estrogen may play a role in OA.
Estrogen has been known to act via estrogen receptors
(ERs). Recently, it has also been reported that there are two
subtypes of ERs, ERα and ERβ [7, 13]. Kuiper et al. demon-
strated the distribution of both ERα and ERβ genes in rat
tissues by using reverse transcription-polymerase chain
reaction (RT-PCR). The expression of ERα was moderate
to strong in the uterus, testes, pituitary, ovaries, kidneys,
epididymis, and adrenal tissues. ERβ showed a similar
expression pattern in the prostate, ovaries, lungs, bladder,
brain, uterus, and testes [8]. Brandenberger et al. performed
RT-PCR using human fetal tissues and found that ERα
occurred most abundantly in the uterus, while high amounts
of ERβ were found in the ovaries, testes, adrenal tissue, and
spleen [2].
Ushiyama  et al. demonstrated the expression of the
ERα and ERβ genes in human articular chondrocytes by
using RT-PCR. They reported that the expression of both the
ERs was higher in men than in women. However, there was
no difference between the joint sites or between the normal
and osteoarthritic cartilage in this regard [24]. Although they
showed that both the ERs are expressed in the articular car-
tilage, the localization of these receptors was not clearly
demonstrated. To evaluate the localization of the ERs,
Yamada et al. demonstrated using immunohistochemistry
the staining of ERα in the articular cartilage of temporoman-
dibular joint in the rat model [27]. ERα-positive chondro-
cytes were found more abundantly in the mature and hyper-
trophic cell layers of the condyle than in the fibrous and
proliferative layers. Using immunohistochemistry, Nilsson
et al. demonstrated the staining of ERβ in the human growthOshima et al. 28
plate cartilage [14]. Chondrocytes in the hypertrophic layer
were well stained, but no staining was observed in the chon-
drocytes in the resting and proliferative layers.
It has not been determined whether ERα and ERβ are
expressed in all the layers of the loading joint articular carti-
lage. Further, the difference in the expression of ERα and
ERβ and whether ER expression is affected by the aging
process in vivo remain unclear.
In this study, we performed the immunofluorescence
staining of ERα and ERβ in the rat femoral cartilage, paying
special attention to the location of the ERs; we also
attempted to identify differences arising due to the effects of
sex, aging, or ovariectomy.
II. Materials and Methods
Animals
Male 3-month-old (n=3), and female 1-day (n=3), 1-
week (n=3), 1-month (n=3), 3-month (n=6), and 24-month-
old (n=3) Wistar rats were used. Moorthy et al. reported that
young female rats (3 months old) show 4 or 5 days estrous
cycles, but that during the aging process irregular cycles
occur in some of the female rats at the age of 12 months [12].
Lu et al. reported that incidence of irregular cycle in aging
rats increased to 65% over 12 months of age [10]. In this
study 24-month-old rats were used as aging rats.
All experimental procedures were approved by the
Committee for Animal Research, Kyoto Prefectural Univer-
sity of Medicine, Japan.
Ovariectomy treatment
Female 3-month-old rats (n=3) were anesthetized by
intraperitoneal injection of sodium pentobarbital (35 mg/kg
body weight), and were bilaterally ovariectomized (OVX)
under sterile surgical technique. Rats were allowed to move
freely after the operation in a temperature-controlled envi-
ronment with a 12-hr light-dark cycle, then sacrificed 1
month after OVX as previously described [10]. In this exper-
iment we used OVX rats as a model in which the production
of estrogen had decreased. The mean plasma concentration
of estradiol in OVX-rats and 3-month-old female rats was
10 pg/ml and 40 pg/ml (30–50 pg/ml) (preliminary data),
respectively.
Histological evaluation
Rats were anesthetized with sodium pentobarbital,
perfused with physiological saline, then fixed with 4%
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB).
Distal parts of the femora were post-fixed in a fixative solu-
tion (4% PFA in 0.1 M PB) for 24 hr at 4°C, then decalcified
with 0.5 M EDTA (pH 7.5, Wako, Osaka, Japan) for 2 weeks
at room temperature (RT). After 2 weeks of decalcification,
gradient replacement with 20% sucrose for 24 hr at 4°C was
performed. The femora were then quick-frozen and cut into
14  µm thick sections on a cryostat (CM3050 S, Leica,
Nussloch, Germany) as previously described [17, 18]. Final-
ly, the sections were stained with 0.05% toluidine blue for
histological examination.
Immunofluorescence staining
Subsequent sections, immediately following those
which were stained with toluidine blue, were used for the
immunofluorescence staining. The slides were rinsed 3
times with phosphate buffered saline 0.09% NaCl in 0.02 M
PB for 5 min, then treated with 0.3% Triton X-100, 1%
bovine serum albumin (BSA) in PBS for 30 min at RT. The
slides were incubated for 60 hr with a rabbit polyclonal anti-
ERα IgG (MC-20, Santa Cruz Biotechnology Inc., CA,
USA) [22], or ERβ IgG (Z8P, Zymed Laboratories Inc., CA,
USA) [3, 6, 16], at a dilution of 1:200 in 0.3% Triton X-100,
1% BSA in PBS at 4°C. The slides were rinsed 3 times with
PBS for 5 min, then incubated with Alexa 488 labeled anti-
rabbit IgG antibody at a dilution of 1:1000 in 0.1% Triton X-
100, 2% BSA in PBS, for 2 hr at 4°C. Following a rinse (3
times) with PBS for 5 min at RT, the sections were embed-
ded in Gelvatol (13% polyvinyl alcohol, 33% glycerol in 0.2
M Tris HCl) and were evaluated by confocal laser scanning
microscope (LSM 510 META, ZEISS, Jena, Germany).
III. Results
Both ERα and ERβ antibodies are commercially avail-
able, and the specificity has been proved in many tissues [3,
6, 16, 22]. A positive control study showed the immunoreac-
tivity for ERα and ERβ in PFA fixed pituitary tissue was
located in the region of anterior lobe cells, which was the
same reactivity as previously reported [15] (data not shown).
In addition, a negative control study of immunohistochemi-
cal staining was performed using the same staining proce-
dure, this time without the rabbit anti-mouse ERs. There
were no signals in these particular sections (data not shown).
One-day-old female
The shape of femoral bone had already been formed,
but the endochondral ossification was not complete at this
time interval. Almost all epiphyseal areas showed metachro-
matic staining by toluidine blue, indicating the existence of
cartilage matrix, and the cellularity of epiphyseal areas was
very high (Fig. 1A). Almost all of the cells in both the super-
ficial and the deep layers of epiphyseal areas were stained
with ERα and ERβ including their nucleus and cytoplasm
(Fig. 1D, E arrows, arrowheads). Both the cytoplasm and
nuclei seemed to be stained in most cells; however, only the
cytoplasm or only the nuclei were stained in some cells by
these antibodies. There were no remarkable differences
between the stained cell number of ERα and ERβ, and ERα
tended to stain stronger than ERβ (Fig. 1B, C, Table 1).
One-week-old female
Almost all of the epiphyseal areas still showed meta-
chromatic staining by toluidine blue at this time interval
(Fig. 2A). Nearly all cells in both the superficial and the
deep layers were stained with ERα and ERβ including their
nucleus and cytoplasm (Fig. 2D arrow, arrowhead). ThereEstrogen Receptors in the Articular Surface 29
was no remarkable change compared to the one-day-old
models, and the cells still stained stronger by ERα than by
ERβ (Fig. 2B, C, Table 1).
One-month-old female
Endochondral ossification was started, and subchon-
dral bone had formed; however, articular cartilage was not
well developed at this time interval (Fig. 3A). Almost all of
the cells in both the articular cartilage and subchondral bone
layers were stained with ERα and ERβ. The strength of the
ERα signal was similar to that of ERβ (Fig. 3B, C, Table 1).
Three-month-old female and male
Articular cartilage and subchondral bone were mature
and well formed at this time interval (Figs. 4A, 5A). In the
female rats, almost all of the cells in the superficial layer of
the articular cartilage were stained with ERα and ERβ (Fig.
4B, C). However, some of the cells in the deeper layers of
Fig. 1. 1-day-old female rat. Femoral epiphyseal areas were stained by toluidine blue (A), indicating the existence of cartilage matrix. In the low
magnification images, almost all of the cells in both the superficial (s) and the deep (d) layers of epiphyseal areas were stained with ERα (B) and
ERβ (C). In the high magnification images, both nucleus and cytoplasm were stained diffusely with ERα (D) and ERβ (E). Arrowheads show
the cells that were stained with ERs mainly in the cytoplasm, and arrows show the cells that were stained with ERs mainly in the nucleus. Bars=5
µm (A, D, E), 20 µm (B, C).
Table 1. Changes of intracellular localization of ERs and immunoreactive level of ERs during aging process and by ovariectomy
Both ERα and ERβ were stained diffusely in not only nucleus but also cytoplasm. With aging, the immunoreactivity level of ERα and ERβ got
weaker, and the aged female rats and OVX rats exhibited lower number of stained cells than immature and mature female rats. (+); higher
immunoreactivity, (±); lower immunoreactivity.
immunoreactive level of ERα immunoreactive level of ERβ






twenty four-month-old female ±±++
one month after OVX female ± ±±±Oshima et al. 30
articular cartilage and subchondral bone layers were not
stained with both ERs (Fig. 4B, C arrows). Similarly, almost
all of the male rat cells expressed both ERα and ERβ. This
was particularly evident in the superficial layer (Fig. 5B, C,
Table 1).
Twenty-four-month-old female
There was no remarkable degradative change on the
articular surface; however, the thickness of cartilage layer
was thinner than that of the younger models (Fig. 6A). Some
of the cells in the superficial layer of the articular cartilage
were stained with ERα and ERβ including nucleus and cyto-
plasm (Fig. 6D, E arrows, arrowheads), but the number of
ERα stained cells had decreased. Only a few cells in the
deeper layers of articular cartilage and subchondral bone
were stained with both ERα and ERβ (Fig. 6B, C, Table 1).
Fig. 2. 1-week-old female rat. In the low magnification images, femoral epiphysial areas still stained by toluidine blue (A), in which almost all
of the cells in both the superficial (s) and the deep (d) layers were stained with ERα (B) and ERβ (C). In the high magnification image, arrow-
head shows the cell that was stained with ERs mainly in the cytoplasm, and arrow shows the cell that was stained with ERs mainly in the nucleus
(D). Bars=5 µm (A, D), 20 µm (B, C).
Fig. 3. 1-month-old female rat. Articular surface was constructed with articular cartilage and subchondral bone layers (A). Almost all of the cells
in both the articular cartilage and subchondral bone layers were stained with ERα (B) and ERβ (C). Bar=50 µm.Estrogen Receptors in the Articular Surface 31
One month after OVX female
There were no remarkable symptoms of inflammation
or infection after OVX treatment. Compared to the articular
surface of 3-month-old female, there was no remarkable
degradation or osteoarthritic change 1 month after OVX in
toluidine blue staining (Fig. 7A). While there was no differ-
ence between ERα and ERβ, the number of stained cells had
dramatically decreased, and the results were similar to those
of aged rat models (Fig. 7B, C, Table 1).
IV. Discussion
In order to evaluate the localization and changes of
ERα and ERβ expressions in articular surface due to gender,
aging, or ovariectomy, immunofluorescence staining was
performed using a rat model. The results showed that both
ERα and ERβ were located and expressed in the articular
cartilage and subchondral bone of young and mature female
rats and mature male rats. In young rats, the degree of ERα
staining appeared to be stronger than that of ERβ; however,
the number of stained cells was similar between ERα and
ERβ. With aging or by OVX, the degree of staining of the
ERα became weaker. As compared to the mature female
rats, the aged female rats and OVX rats exhibited a marked
lower number of ERα stained cells. In aging rats, the stain-
ing degree of ERβ was same as in mature female rats. The
function of ERβ may be different from that of ERα.
Monje and Boland reported that ERα and ERβ were
localized not only to the nucleus but also the cytoplasm
within the cells in rabbit uterus and ovary [11]. Levin dem-
onstrated that signal transduction had occurred through ERs
in the nucleus, plasma membrane, and cytoplasm including
mitochondria [9]. In our study, ERs were localized in both
nucleus and cytoplasm in the cartilage tissue. As to the sig-
nificance of the intracellular localization of ERα and ERβ, it
is possible that signal pathways through nucleus and cyto-
plasm including mitochondria depend on the estrogen hor-
mone. Estrogen may have some direct effects on the chon-
drocytes through the estrogen receptor.
Because the prevalence and incidence of OA differs not
only between the genders but also between premenopausal
and postmenopausal women, it is considered that degrada-
tion of the articular cartilage is associated with the estrogen
hormone, and that estrogen replacement therapy (ERT) has
an effect on the articular cartilage. Ravn et al. used oral and
transdermal estradiol therapies and evaluated cartilage
Fig. 4. 3-month-old female rat. Cartilage and bone formations were mature (A). In female, almost all of the cells in the superficial (s) layer
(arrows) of the articular cartilage were stained with ERα (B) and ERβ (C). Bar=50 µm.
Fig. 5. 3-month-old male rat. Similar to female, almost all the cells, especially in the superficial (s) layer of articular cartilage (A) expressed both
ERα (B) and ERβ (C). Bar=50 µm.Oshima et al. 32
degradation and bone resorption by measuring the content
of C-telopeptides of type I and type II collagen in urine by
using an enzyme-linked immunosorbent assay (ELISA) [19].
Using magnetic resonance imaging, Wluka et al. calculated
the difference in the amount of knee cartilage in women over
50 years who either had or had not undergone ERT [25]. In
their human study, they concluded that in postmenopausal
women, ERT provided protected against OA and osteoporo-
sis. However, later in their longer follow-up study, Wluka et
al. later reported that ERT had no effect on the cartilage
[26]. Further, Tsai and Liu reported that an intraarticular
injection of estradiol actually induced knee OA in their rab-
bit study. In their experiment, the change in OA was clearly
different between the high- and low-dose groups as well as
Fig. 6. 24-month-old female rat. There was no remarkable degenerative change on the articular surface; however, the cartilage thickness was
thinner than that of the younger models (A). In the low magnification images, some cells in the superficial (s) and a few cells in the deeper (d)
layer of the articular cartilage were stained with ERα (B) and ERβ (C). In the high magnification images, both nucleus and cytoplasm were
stained diffusely with ERα (D) and ERβ (E). Arrowheads show the cells that were stained with ERs mainly in the cytoplasm, and arrows show
the cells that were stained with ERs mainly in the nucleus. Bars=50 µm (A–C), 5 µm (D, E).
Fig. 7. 4-month-old female rat 1 month after OVX. There was no remarkable degradational or osteoarthritic change (A). Similar to the results of
aged rat models, some cells were stained with ERα (B) and ERβ (C). Bar=50 µm.Estrogen Receptors in the Articular Surface 33
between the short and long periods [23]. Further, some other
investigators have also reported that ERT has no significant
effect on the articular cartilage. They considered that con-
flicting results were obtained because of the differences
between human and animal species, sample sizes, in vivo
and in vitro models, estradiol dosage, and duration of the
treatment [23, 24]. Thus, the effect of estrogen on cartilage
has not yet been determined [1, 4, 20].
It has been recognized that there is a relationship
between estrogen and bones, and that estrogen halts or
reduces bone loss in women [1]. Estrogen deficiency causes
osteoporosis, and, therefore, the decreasing mechanical
strength of the subchondral bones may indirectly affect the
articular cartilage [25]. It is also well known that the serum
estrogen level in males is markedly lower and does not
change significantly throughout their life span. Conversely,
the serum estrogen level in women is considerably higher
and decreases significantly after menopause. Our results
showed that ERα and ERβ were expressed on the articular
surface in mature males and both immature and mature
females. Because the plasma estradiol level did not differ
between young male (5 months old) and old male (24
months old) rat [21], the difference of ER expression was
not considered to be associated with the aging process. The
levels of ERα and ERβ in the articular cartilage of the OVX
rats, as a simulation of postmenopause, as well as the levels
of ERα in aged female rats were found to be reduced. These
results suggest that estrogen and ERα expression directly
affect cartilage metabolism throughout life, irrespective of
whether or not this effect is beneficial. We demonstrated the
presence of ERs in the articular cartilage of the loading joint
by using immunofluorescence staining. These results pro-
vide basic data that will facilitate further research on the
relationship among OA, aging, sex, estrogen, and ERs.
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